Healthcare & Life Sciences
Alnylam Pharmaceuticals
United Statesalnylam.com
Alnylam Pharmaceuticals is a Healthcare & Life Sciences startup based in the United States, most recent round Series C+, 3 tracked investors.
Activeseries-c-plus
series-c-plus
Stage
3
Investors
About Alnylam Pharmaceuticals
Alnylam Pharmaceuticals is a startup based in the United States. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 3 investors associated with the company.
Alnylam Pharmaceuticals develops RNA interference (RNAi) therapeutics that silence disease-causing genes to treat both rare and prevalent diseases.
Explore Alnylam Pharmaceuticals's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.